Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration - PubMed (original) (raw)

. 1995 Sep 15;155(6):3135-4.

Affiliations

PMID: 7545712

Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration

H E Chuluyan et al. J Immunol. 1995.

Abstract

We investigated the role of the 6 domain (6D) and 7 domain (7D) forms of human VCAM-1 as counter-receptors for the alpha 4 beta 1 integrin (VLA-4) in monocyte migration induced by C5a. Across Chinese hamster ovary (CHO) cell monolayers transfected with VCAM-6D or VCAM-7D, monocyte migration was not inhibited by treatment of monocytes with mAb to CD18. Addition of mAb to alpha 4 to the CD18 mAb inhibited monocyte migration by 90% across CHO VCAM-6D and CHO VCAM-7D. mAbs to domain 1 (4B9) or domain 4 (GH12) of VCAM-1 each inhibited migration across CHO VCAM-7D partially, when monocytes were also treated with anti-CD18 mAb. When the VCAM-1 mAbs were combined, migration of these monocytes across CHO VCAM-7D was further inhibited to the same degree as with mAbs to alpha 4 plus CD18. IL-1-treated human umbilical vein endothelium (HUVE) supported CD18-independent, VLA-4-mediated monocyte migration to C5a. A mAb to domain 1 of VCAM-1 almost completely inhibited the CD18-independent migration across HUVE activated with IL-1 for 2 h or 20 h, but was less inhibitory when HUVE was treated with IL-1 for 5 h. However, when mAbs to domain 1 and domain 4 were combined, CD18-independent migration was inhibited completely under all conditions tested. These results suggest that either domain 1 or domain 4 of VCAM-1 can mediate VLA-4-dependent monocyte transendothelial migration, that VLA-4 interaction with these two domains can account for all of the VLA-4-mediated migration, and that the expression of VCAM-1 variants on HUVE depends partly on the duration of IL-1 activation.

PubMed Disclaimer

Cited by

Ataxin-10 Inhibits TNF-_α_-Induced Endothelial Inflammation via Suppressing Interferon Regulatory Factor-1.
Li Y, Zhang Q, Li N, Ding L, Yi J, Xiao Y, Chen S, Huang X. Li Y, et al. Mediators Inflamm. 2021 Nov 23;2021:7042148. doi: 10.1155/2021/7042148. eCollection 2021. Mediators Inflamm. 2021. PMID: 34858081 Free PMC article.
TRIM65 E3 ligase targets VCAM-1 degradation to limit LPS-induced lung inflammation.
Li Y, Huang X, Guo F, Lei T, Li S, Monaghan-Nichols P, Jiang Z, Xin HB, Fu M. Li Y, et al. J Mol Cell Biol. 2020 Apr 24;12(3):190-201. doi: 10.1093/jmcb/mjz077. J Mol Cell Biol. 2020. PMID: 31310649 Free PMC article.
How natalizumab binds and antagonizes α4 integrins.
Yu Y, Schürpf T, Springer TA. Yu Y, et al. J Biol Chem. 2013 Nov 8;288(45):32314-32325. doi: 10.1074/jbc.M113.501668. Epub 2013 Sep 18. J Biol Chem. 2013. PMID: 24047894 Free PMC article.
Regulation of Rela/p65 and endothelial cell inflammation by proline-rich tyrosine kinase 2.
Bijli KM, Fazal F, Rahman A. Bijli KM, et al. Am J Respir Cell Mol Biol. 2012 Nov;47(5):660-8. doi: 10.1165/rcmb.2012-0047OC. Epub 2012 Jul 27. Am J Respir Cell Mol Biol. 2012. PMID: 22842493 Free PMC article.
ROCK1 functions as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability.
Vemula S, Shi J, Hanneman P, Wei L, Kapur R. Vemula S, et al. Blood. 2010 Mar 4;115(9):1785-96. doi: 10.1182/blood-2009-08-237222. Epub 2009 Dec 11. Blood. 2010. PMID: 20008297 Free PMC article.

Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration - PubMed (original) (raw)